NOX 2.94% 6.6¢ noxopharm limited

The statement about Pfizer in the Nox press release is a little...

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    The statement about Pfizer in the Nox press release is a little misleading. Pfizer bought the company Medivation for $14bn which yes gave it enzalutamide but Medivation also had a range of other oncology drugs in its portfolio like PARP inhibitor and a checkpoint inhibitor. IE the deal was about the whole asset pipeline not just enzalutamide. Not surprising as Pfizer is well behind and trying to play catch up in oncology
    take your point about incorrect conflation
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.002(2.94%)
Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.31K 198.1K

Buyers (Bids)

No. Vol. Price($)
1 1137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 15.50pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.